US 11,051,724 B2
Analyte sensor devices, connections, and methods
Louis Pace, San Carlos, CA (US); Peter G. Robinson, Alamo, CA (US); Udo Hoss, Castro Valley, CA (US); Samuel Mason Curry, San Francisco, CA (US); Phillip William Carter, Oakland, CA (US); Vincent Michael DiPalma, Oakland, CA (US); Amit Mhatre, Sunnyvale, CA (US); Jennifer Olson, San Francisco, CA (US); Manuel Luis Miguel Donnay, San Francisco, CA (US); and Marc Barry Taub, Mountain View, CA (US)
Assigned to ABBOTT DIABETES CARE INC., Alameda, CA (US)
Filed by ABBOTT DIABETES CARE INC., Alameda, CA (US)
Filed on Nov. 18, 2020, as Appl. No. 16/951,629.
Application 16/951,629 is a continuation of application No. 15/908,616, filed on Feb. 28, 2018.
Application 15/908,616 is a continuation of application No. 15/610,334, filed on May 31, 2017, granted, now 9,931,066, issued on Apr. 3, 2018.
Application 15/610,334 is a continuation of application No. 15/193,499, filed on Jun. 27, 2016, granted, now 9,693,713, issued on Jul. 4, 2017.
Application 15/193,499 is a continuation of application No. 13/710,460, filed on Dec. 11, 2012, granted, now 9,402,570, issued on Aug. 2, 2016.
Claims priority of provisional application 61/569,287, filed on Dec. 11, 2011.
Prior Publication US 2021/0068721 A1, Mar. 11, 2021
Int. Cl. A61B 5/00 (2006.01); A61B 5/145 (2006.01); A61B 5/15 (2006.01); A61B 5/151 (2006.01); A61B 5/157 (2006.01); H04L 29/08 (2006.01); A61B 50/30 (2016.01)
CPC A61B 5/14503 (2013.01) [A61B 5/0004 (2013.01); A61B 5/145 (2013.01); A61B 5/1411 (2013.01); A61B 5/1451 (2013.01); A61B 5/14532 (2013.01); A61B 5/157 (2013.01); A61B 5/150022 (2013.01); A61B 5/15087 (2013.01); A61B 5/15105 (2013.01); A61B 5/15144 (2013.01); A61B 5/150305 (2013.01); A61B 5/150335 (2013.01); A61B 5/150358 (2013.01); A61B 5/150389 (2013.01); A61B 5/150503 (2013.01); A61B 5/150748 (2013.01); A61B 5/150877 (2013.01); A61B 5/6849 (2013.01); A61B 50/3001 (2016.02); H04L 67/12 (2013.01); A61B 2560/0406 (2013.01); A61B 2560/0443 (2013.01); A61B 2560/063 (2013.01); A61B 2562/16 (2013.01); A61B 2562/242 (2013.01)] 27 Claims
OG exemplary drawing
 
1. An on-body device, comprising:
(1) a glucose sensor assembly comprising:
a proximal section comprising a connector support coupled with a proximal portion of a glucose sensor;
a distal tail section comprising a distal portion of the glucose sensor configured to be positioned under a skin surface and in contact with a bodily fluid of a subject;
(2) a housing comprising:
a top portion;
a base portion configured to be adhered to the skin surface of the subject by an adhesive patch; and
a first space defined by the top portion and the base portion; and
(3) sensor electronics positioned within the first space,
wherein the base portion of the housing comprises a recess in a bottom exterior surface, the recess comprising a distal-facing opening, wherein the recess defines a second space different from the first space,
wherein the connector support is received through the distal-facing opening and into the recess, and
wherein the glucose sensor is electrically coupled with the sensor electronics by the connector support when the connector support is received into the recess.